Aspira Pathlab & Diagnostics Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 6.25 | 4.73 | 3.89 |
| Operating Expense | 4.82 | 4.29 | 3.94 |
| Net Profit | 0.99 | -0.02 | -0.50 |
| Net Profit Margin | 15.84 | -0.42 | -12.85 |
| Earning Per Share | 0.96 | -0.02 | -0.49 |
| EBIDTA | 1.43 | 0.44 | -0.04 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 6.25 |
| Operating Expense | 4.82 |
| Net Profit | 0.99 |
| Net Profit Margin | 15.84 |
| Earning Per Share | 0.96 |
| EBIDTA | 1.43 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 13.20 | 14.46 | 19.54 |
| Operating Expenses Annual | 14.39 | 12.86 | 13.17 |
| Operating Profit Annual | -0.77 | 1.91 | 6.47 |
| Interest Annual | 0.37 | 0.42 | 0.37 |
| Depreciation | 1.51 | 1.53 | 1.58 |
| Net Profit Annual | -2.67 | -0.09 | 4.46 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 13.20 |
| Operating Expenses Annual | 14.39 |
| Operating Profit Annual | -0.77 |
| Interest Annual | 0.37 |
| Depreciation | 1.51 |
| Net Profit Annual | -2.67 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.57 | 1.35 | 1.19 |
| Cash Flow from Operations | 1.05 | -0.01 | 2.03 |
| Cash Flow from Investing | 0.14 | 0.16 | -0.51 |
| Cash Flow from Financing | -0.95 | -0.94 | -1.35 |
| Cash Flow at the End | 0.80 | 0.57 | 1.35 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.57 |
| Cash Flow from Operations | 1.05 |
| Cash Flow from Investing | 0.14 |
| Cash Flow from Financing | -0.95 |
| Cash Flow at the End | 0.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -5.76 | 13.28 | 33.11 |
| PBIT Margin (%) | -17.42 | 2.28 | 24.72 |
| PBT Margin (%) | 29.70 | -3.18 | -42.07 |
| Net PROFIT Margin (%) | -20.23 | -0.62 | 22.82 |
| Return On Networth / Equity (%) | TBA | TBA | 23.08 |
| Return On Networth /Employed (%) | TBA | TBA | 17.56 |
| Return On Assets (%) | -18.00 | -0.54 | 32.41 |
| Total Debt / Equity (X) | 0.16 | 0.20 | 0.19 |
| Asset Turnover Ratio (%) | 0.89 | 0.87 | 1.42 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -5.76 |
| PBIT Margin (%) | -17.42 |
| PBT Margin (%) | 29.70 |
| Net PROFIT Margin (%) | -20.23 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -18.00 |
| Total Debt / Equity (X) | 0.16 |
| Asset Turnover Ratio (%) | 0.89 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 6.79 | 8.01 | 9.57 |
| Total Current Assets Annual | 4.36 | 5.86 | 7.14 |
| Non Current Assets Annual | 10.35 | 11.49 | 10.99 |
| Total Shareholders Funds Annual | 10.14 | 12.75 | 12.79 |
| Total Assets Annual | 14.71 | 17.34 | 18.14 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 6.79 |
| Total Current Assets Annual | 4.36 |
| Non Current Assets Annual | 10.35 |
| Total Shareholders Funds Annual | 10.14 |
| Total Assets Annual | 14.71 |
EPS (INR)
Expected
0.96
Reported
0.96
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Jun 2023
EPS beaten by 0.00%
